
Menactra Vaccine
Description
Menactra Vaccine is used to prevent meningococcal disease. This is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C,Y and W-135. It is approved for use in individuals 9 months through 55 years of age.
Product Information
Form
Vial (Intramuscular injection)
Strength
0.5ml per dose (64 mcg)
Pack Size
1 vial of 0.5ml
Storage
Store at 2°C to 8°C
Manufactured By
Sanofi Pasteur Inc.
Marketed By / TM Owner
Sanofi Pasteur India Pvt. Ltd
Institutional Quality & Supply Assurance
Meeting Global Pharmaceutical Standards for Trusted International Trade
Procured through authorised distributors and companies, ensuring reliable quality and supply chain traceability.
Active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Pre-dispatch inspection, tamper-evident packing, and documentation verification for every shipment.
Uses
Treatment of Meningococcal disease
Disclaimer
At ExSell Laboratories Pvt. Ltd., we aim to provide information that is accurate and reliable. All content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While every effort is made to maintain accuracy, the information provided may contain errors or omissions, or may not reflect the latest developments. Please consult a qualified healthcare professional regarding any medical concerns.
All product names, brand names, trademarks, and registered trademarks displayed on this website are the property of their respective owners. ExSell Laboratories Pvt. Ltd. and this website are not affiliated with, endorsed by, or authorized by any such trademark owners, unless expressly stated. References to product names or trademarks are made solely for descriptive and informational purposes, and no commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Nothing herein constitutes promotion, advertising, or an offer for sale of any medicinal product.
All trademarks and brand names on this website are used strictly in accordance with the Trade Marks Act, 1999 — specifically Sections 30 and 30(1) governing fair use — and any related parallel trade is conducted consistent with the trademark exhaustion and fair-use provisions of the Act, as well as India's obligations as a WTO member under the TRIPS Agreement.
"Trademark ownership is duly attributed under the 'Marketing/TM Owner' section in accordance with applicable statutory requirements."
Frequently Asked Questions about Menactra Vaccine
Essential information on active composition, quality standards, cold-chain storage, and international export.
What is Menactra Vaccine and what active ingredient does it contain?
Menactra Vaccine is a certified pharmaceutical product from our Global export catalogue formulated as a Vial (Intramuscular injection) (0.5ml per dose (64 mcg)). It contains the active pharmaceutical ingredient Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg), manufactured by Sanofi Pasteur Inc..
Who manufactures Menactra Vaccine and is it quality certified?
Menactra Vaccine is manufactured by Sanofi Pasteur Inc. – Meeting Global Pharmaceutical Standards for Trusted International Trade. ExSell Laboratories delivers authenticated batches sourced through verified, compliant supply channels, backed by complete regulatory documentation.
How should Menactra Vaccine be stored to maintain potency?
Menactra Vaccine must be stored according to manufacturer instructions: Store at 2°C to 8°C. ExSell Laboratories maintains active temperature logging during air cargo export, maintaining Refrigerated (2°C–8°C) and CRT (15°C–25°C) conditions as per international shipping standards.
Can Menactra Vaccine be ordered in bulk for international export?
Yes, ExSell Laboratories is a licensed global pharmaceutical exporter supplying hospitals, pharmacies, government procurement agencies, and distributors in 45+ countries. Contact our sales team for bulk quotation, MOQ, and international shipping options.
Substitutes & Brands with Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg)
Verified equivalent brands and bioequivalent formulations containing Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg).

Menveo Vaccine
Meningococcal Vaccine (Group A, C, Y & W-135)

Dostiheal 0.50mg Tablet
Cabergoline 0.5mg

Tranexaheal 500mg Tablet
Tranexamic Acid 500mg

Colchiheal 0.5mg Tablet
Colchicine 0.5mg
Menactra Vaccine
0.5ml per dose (64 mcg)